McKesson Corp. (MCK) Dividend Details and dates on New York Stock Exchange

McKesson Corp. Dividend Stock Review

New York Stock Exchange

McKesson Corp. (MCK) Dividend Details and dates on New York Stock Exchange

McKesson Corp. McKesson Corp. engages in the provision of supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology. It operates through the following segments: U.S. Pharmaceutical and Specialty Solutions; European Pharmaceutical Solutions; Medical-Surgical Solutions and Other. The U.S. Pharmaceutical and Specialty Solutions segment distributes pharmaceutical and other healthcare-related products and also provides pharmaceutical solutions to pharmaceutical manufacturers in the United States. The European Pharmaceutical Solutions segment provides distribution and services to wholesale, institutional and retail customers and serves patients and consumers in 13 European countries. The Medical-Surgical Solutions segment focuses on medical-surgical supplies and provides logistics and other services to healthcare providers in the United States. The Other segment comprises on McKesson Canada, McKesson Prescription Technology Solutions and in a joint venture. The company was founded by John McKesson and Charles Olcott in 1833 and is headquartered in Irving, TX.
Sector: Distribution Services Medical Distributors

Dividend income advisory for MCK
Dividend Yield for MCK
The expected yield for MCK is 1.15 %, which can be considered at the lower side, after taxation the dividend will return barely more than inflation.

How is MCK priced
MCK has a trailing price to earnings ratio (P/E) of 1454. The ratio is determined by the performance in the last 12 months. The P/E of MCK is at the high side, this mostly means the asset is valued to account for future revenue of profits of McKesson Corp..

Debt to equity of MCK
With the Debt To Equity rate of MCK (0.94) we can conclude that McKesson Corp. does not seem to have more liabilities than equity provided by the shareholders. A lower D/E ratio stands for a less risky investment.

Price Prediction for MCK
On average analists predict that MCK will be correctly priced after a 9%. change. We can expect some long term capital gains.

Upcoming Dividends for MCK
Declared Ex Dividend Date Payment Date Record Date Amount Frequency
2019-04-24 2019-05-31 2019-07-01 2019-06-03 0.39 USD Quarterly


Dividends in past 12 months MCK
Declared Ex Dividend Date Payment Date Record Date Amount Frequency
2019-01-31 2019-02-28 2019-04-01 2019-03-01 0.39 USD Quarterly
2018-10-25 2018-11-30 2019-01-02 2018-12-03 0.39 USD Quarterly
2018-07-26 2018-08-31 2018-10-01 2018-09-04 0.39 USD Quarterly
2018-04-25 2018-05-31 2018-07-02 2018-06-01 0.34 USD Quarterly


Historical Dividends & Cap Growth for MCK
Past 5 Year Capital Gains -38.66 %
Dividend yield 3.03 %
Growth including dividends -35.62%
Latest news for MCK

2019-05-08 McKesson meets full-year profit estimates, renews partnership with CVS U.S. drug distributor McKesson Corp forecast a full-year profit on Wednesday that matched analysts' estimates, easing some fears over drug pricing pressures and costs of opioid-related litigations.
Original Article @ Reuters India

2019-05-08 McKesson Corp (MCK) Q4 2019 Earnings Call Transcript MCK earnings call for the period ending March 31, 2019.
Original Article @ The Motley Fool

2019-05-08 Drug distributor McKesson's fourth-quarter profit beats estimates McKesson Corp beat fourth-quarter profit estimates on Wednesday, as the recent acquisition of Medical Specialties Distributors LLC boosted the U.S. drug distributor's surgical distribution business.
Original Article @ Reuters India

2019-05-08 UPDATE 2-McKesson meets full-year profit estimates, renews partnership with CVS U.S. drug distributor McKesson Corp forecast a full-year profit on Wednesday that matched analysts' estimates, easing some fears over drug pricing pressures and costs of opioid-related litigations.
Original Article @ Reuters

2019-05-08 McKesson Gets Some Growth Back The drug distributor isn’t back to full strength, but it has investors a bit more comfortable about its future.
Original Article @ The Motley Fool

2019-05-08 McKesson (MCK) Tops Q4 Earnings Estimates McKesson (MCK) delivered earnings and revenue surprises of 0.82% and -1.73%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
Original Article @ Zacks Investment Research

2019-05-08 McKesson stock up 1.3% after company posts earnings above Wall Street expectations Shares of McKesson Corp. rose 1.3% in premarket trade Wednesday after the company reported fourth-quarter earnings that beat Wall Street expectations, though…
Original Article @ MarketWatch

2019-05-08 Drug distributor McKesson posts smaller 4th-qtr loss U.S. drug distributor McKesson Corp reported a smaller fourth-quarter loss on Wednesday, as its surgical distribution business was boosted by the company's recent acquisition of Medical Specialties Distributors LLC.
Original Article @ Reuters

2019-05-08 McKesson beats by $0.03, misses on revenue No summary available.
Original Article @ Seeking Alpha

2019-05-08 10 Stocks To Watch For May 8, 2019 Some of the stocks that may grab investor focus today are: Wall Street expects McKesson Corporation (NYSE: MCK) to report quarterly earnings at $3.66 per …
Original Article @ Benzinga

Dividend Stats For MCK

  • Current Dividend Yield 1.15%
  • Past Year Payout: 1.51 USD
  • Next Ex Dividend 2019-05-31
  • Next Payment: 0.39 USD
  • Our score 26 %

Related dividend stocks